Linyu Wu

991 total citations · 2 hit papers
11 papers, 647 citations indexed

About

Linyu Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Linyu Wu has authored 11 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Linyu Wu's work include RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Circular RNAs in diseases (2 papers). Linyu Wu is often cited by papers focused on RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Circular RNAs in diseases (2 papers). Linyu Wu collaborates with scholars based in China, United States and Hong Kong. Linyu Wu's co-authors include Yuhui Tang, W. H. Tian, Jindong Xie, Yutian Zou, Xinpei Deng, Chau‐Wei Wong, Xiaoming Xie, Shaoquan Zheng, Duxun Tan and Song Wu and has published in prestigious journals such as Frontiers in Immunology, Advanced Science and Cancer Letters.

In The Last Decade

Linyu Wu

11 papers receiving 646 citations

Hit Papers

Leveraging diverse cell-death patterns to predict the pro... 2022 2026 2023 2024 2022 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
    2022 248 citations Yutian Zou, Jindong Xie et al. International Journal of Surgery profile →
  2. The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
    2022 191 citations Yutian Zou, Feng Ye et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linyu Wu China 9 384 271 234 204 126 11 647
Chau‐Wei Wong China 6 334 0.9× 233 0.9× 195 0.8× 204 1.0× 130 1.0× 6 582
Jonathan T. Lei United States 11 263 0.7× 207 0.8× 130 0.6× 175 0.9× 97 0.8× 30 585
Karama Asleh Canada 12 275 0.7× 177 0.7× 217 0.9× 314 1.5× 121 1.0× 25 669
Huili Chu China 12 442 1.2× 187 0.7× 244 1.0× 276 1.4× 65 0.5× 15 710
Prashanth Prithviraj Australia 13 319 0.8× 193 0.7× 155 0.7× 405 2.0× 192 1.5× 28 753
Hongle Li China 16 421 1.1× 191 0.7× 267 1.1× 220 1.1× 74 0.6× 44 724
Xianqiu Wu China 15 483 1.3× 115 0.4× 223 1.0× 193 0.9× 93 0.7× 26 740
Erwin Tomasich Austria 13 336 0.9× 120 0.4× 187 0.8× 179 0.9× 72 0.6× 31 547

Countries citing papers authored by Linyu Wu

Since Specialization
Citations

This map shows the geographic impact of Linyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyu Wu more than expected).

Fields of papers citing papers by Linyu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyu Wu. The network helps show where Linyu Wu may publish in the future.

Co-authorship network of co-authors of Linyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Linyu Wu. A scholar is included among the top collaborators of Linyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linyu Wu. Linyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tan, Yeru, Jingping Yuan, Hailin Tang, et al.. (2024). circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Letters. 592. 216907–216907. 23 indexed citations
2.
Wu, Linyu, Shanshan Huang, W. H. Tian, et al.. (2024). PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer. Cell Death Discovery. 10(1). 7–7. 25 indexed citations
3.
Tian, W. H., Yuhui Tang, Jindong Xie, et al.. (2023). AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death and Disease. 14(12). 790–790. 17 indexed citations
4.
Tian, W. H., Yuhui Tang, Yanan Kong, et al.. (2023). Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences. 19(5). 1645–1663. 20 indexed citations
5.
Zou, Yutian, Feng Ye, Yanan Kong, et al.. (2022). The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced Science. 10(5). e2203699–e2203699. 191 indexed citations breakdown →
6.
Zou, Yutian, Jindong Xie, Shaoquan Zheng, et al.. (2022). Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. International Journal of Surgery. 107. 106936–106936. 248 indexed citations breakdown →
7.
Tang, Yuhui, W. H. Tian, Jindong Xie, et al.. (2022). Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature. Frontiers in Immunology. 13. 843515–843515. 62 indexed citations
8.
Xie, Jindong, W. H. Tian, Yuhui Tang, et al.. (2022). Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9. 834593–834593. 35 indexed citations
9.
Zou, Yutian, Jindong Xie, W. H. Tian, et al.. (2022). Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 839986–839986. 7 indexed citations
10.
Xiong, Zhenchong, Xing Li, Lin Yang, et al.. (2022). Integrative Analysis of Gene Expression and DNA Methylation Depicting the Impact of Obesity on Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 818082–818082. 6 indexed citations
11.
Zhang, Yue, Duxun Tan, Yi Xie, et al.. (2022). CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis. Journal of Oncology. 2022. 1–11. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chau‐Wei Wong Breakdown of academic impact, for papers by Jonathan T. Lei Breakdown of academic impact, for papers by Karama Asleh Breakdown of academic impact, for papers by Huili Chu Breakdown of academic impact, for papers by Prashanth Prithviraj Breakdown of academic impact, for papers by Hongle Li Breakdown of academic impact, for papers by Xianqiu Wu Breakdown of academic impact, for papers by Erwin Tomasich
Rankless by CCL
2026